178 related articles for article (PubMed ID: 30221599)
1. Drug Target Selection for Trypanosoma cruzi Metabolism by Metabolic Control Analysis and Kinetic Modeling.
Saavedra E; González-Chávez Z; Moreno-Sánchez R; Michels PAM
Curr Med Chem; 2019; 26(36):6652-6671. PubMed ID: 30221599
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Control Analysis for Drug Target Prioritization in Trypanosomatids.
González-Chávez Z; Vázquez C; Moreno-Sánchez R; Saavedra E
Methods Mol Biol; 2020; 2116():689-718. PubMed ID: 32221950
[TBL] [Abstract][Full Text] [Related]
3. Drug target validation of the trypanothione pathway enzymes through metabolic modelling.
Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E
FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478
[TBL] [Abstract][Full Text] [Related]
4. Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target.
González-Chávez Z; Olin-Sandoval V; Rodíguez-Zavala JS; Moreno-Sánchez R; Saavedra E
Biochim Biophys Acta; 2015 Feb; 1850(2):263-73. PubMed ID: 25450181
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
[TBL] [Abstract][Full Text] [Related]
6. Targeting trypanothione metabolism in trypanosomatid human parasites.
Olin-Sandoval V; Moreno-Sánchez R; Saavedra E
Curr Drug Targets; 2010 Dec; 11(12):1614-30. PubMed ID: 20735352
[TBL] [Abstract][Full Text] [Related]
7. Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification.
Irigoín F; Cibils L; Comini MA; Wilkinson SR; Flohé L; Radi R
Free Radic Biol Med; 2008 Sep; 45(6):733-42. PubMed ID: 18588970
[TBL] [Abstract][Full Text] [Related]
8. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.
Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R
Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
10. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
[TBL] [Abstract][Full Text] [Related]
11. Metabolic control analysis of the transsulfuration pathway and the compensatory role of the cysteine transport in Trypanosoma cruzi.
Vázquez C; Encalada R; Belmont-Díaz J; Rivera M; Alvarez S; Nogueda-Torres B; Saavedra E
Biosystems; 2023 Dec; 234():105066. PubMed ID: 37898397
[TBL] [Abstract][Full Text] [Related]
12. Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi.
Wilkinson SR; Temperton NJ; Mondragon A; Kelly JM
J Biol Chem; 2000 Mar; 275(11):8220-5. PubMed ID: 10713147
[TBL] [Abstract][Full Text] [Related]
13. Trypanothione biosynthesis in Leishmania major.
Oza SL; Shaw MP; Wyllie S; Fairlamb AH
Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
[TBL] [Abstract][Full Text] [Related]
14. Properties of trypanothione synthetase from Trypanosoma brucei.
Oza SL; Ariyanayagam MR; Aitcheson N; Fairlamb AH
Mol Biochem Parasitol; 2003 Sep; 131(1):25-33. PubMed ID: 12967709
[TBL] [Abstract][Full Text] [Related]
15. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development.
Schmidt A; Krauth-Siegel RL
Curr Top Med Chem; 2002 Nov; 2(11):1239-59. PubMed ID: 12171583
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
17. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids.
Fairlamb AH; Blackburn P; Ulrich P; Chait BT; Cerami A
Science; 1985 Mar; 227(4693):1485-7. PubMed ID: 3883489
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Cross-Talk of Redox Metabolism and Fe-S Cluster Biogenesis in Leishmania Through Systems Biology Approach.
Kumar A; Chauhan N; Singh S
Front Cell Infect Microbiol; 2019; 9():15. PubMed ID: 30778378
[TBL] [Abstract][Full Text] [Related]
19. Metabolic control analysis as a strategy to identify therapeutic targets, the case of cancer glycolysis.
Marín-Hernández Á; Saavedra E
Biosystems; 2023 Sep; 231():104986. PubMed ID: 37506818
[TBL] [Abstract][Full Text] [Related]
20. Polyamine metabolism in Leishmania: from arginine to trypanothione.
Colotti G; Ilari A
Amino Acids; 2011 Feb; 40(2):269-85. PubMed ID: 20512387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
